
Biogen
OrganizationHeard in 19 episodes across 12 shows since Apr 2026
Biogen Inc. is a publicly traded American biotechnology company headquartered in Cambridge, Massachusetts, focused primarily on discovering, developing, and commercializing medicines for neurological and neurodegenerative diseases. The podcast references describe Biogen in that core context: its Alzheimer’s tau-focused drug research, partnerships such as a neurology collaboration with City Therapeutics, and its broader role as a major biopharmaceutical company; one market segment also refers to its stock under the ticker BIIB.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Biogen per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 7 | 0.01‰ | 1 |
| Sep 22 | 0.03‰ | 3 |
| Oct 6 | 0.01‰ | 1 |
| Oct 7 | 0.02‰ | 1 |
| Oct 16 | 0.02‰ | 2 |
| Oct 20 | 0.03‰ | 1 |
| Oct 21 | 0.03‰ | 1 |
| Oct 23 | 0.02‰ | 1 |
| Oct 28 | 0.02‰ | 1 |
| Nov 2 | 0.02‰ | 1 |
| Nov 6 | 0.02‰ | 1 |
| Nov 20 | 0.01‰ | 1 |
Email alert
Email me when Biogen comes up on a podcast
One email a week at most, with the new episodes that mention Biogen. Free, no account needed, unsubscribe in one click.
What experts have said about Biogen
6 statements · 5 positive · 1 negative
Investors should consider taking profits on Biogen.
“maybe now is a good time to at least take some of those profits off the table”
Open the episode · 3 Stocks to Sell and 3 Stocks to Buy for NovemberListen at 22:05
Biogen’s chart remains potentially actionable after reclaiming its buy point.
“the chart's not broken, I'm going to say this is still potentially actionable.”
Open the episode · Chips Send Nasdaq To New Highs; Micron, Shopify, Biogen In FocusListen at 17:27
Biogen is among the stronger individual medical stocks and is actionable.
“I think Biogen is right up there in terms of that, you know, retaking that buy point to me does make it actionable.”
Open the episode · Chips Send Nasdaq To New Highs; Micron, Shopify, Biogen In FocusListen at 18:52
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
19 episodes featuring Biogen, newest first
- Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Nov 2, 2026
Six stock calls follow a technology-led market sell-offThe Morning FilterNov 2, 2026 - Oct 28, 2026
Apple’s hardware edge meets the bottlenecks of AI’s next phaseTBPNOct 28, 2026 - Oct 26, 2026
Anthropic filing puts AI’s capital demands under the market’s microscopeClosing BellOct 26, 2026 - Oct 23, 2026
AI challenges biotech’s old company modelBiotech HangoutOct 23, 2026